-Suppression of tumor growth in vivo -Increase in K5 and involucrin expression in CSCC cells-Promotion of epithelial differentiation-Inhibition of angiogenesis-Reduction of cisplatin resistance in CSCC. This evidence concerns the gene KRT5 and neoplasm.